Back to search

Tetrathiomolybdate therapy protects against bleomycin-induced pulmonary fibrosis in mice

Data up to Jan 2025

Published2003
Citations74
References28

Total Citations Per Year

Abstract

References (28)

Transforming Growth Factor β in Tissue Fibrosis

1994 • 3,055 citations

Measurement of Ceruloplasmin from Its Oxidase Activity in Serum by Use of o-Dianisidine Dihydrochloride

1974 • 595 citations

The Connective Tissue Growth Factor/Cysteine- Rich 61/Nephroblastoma Overexpressed (CCN) Family*

1999 • 567 citations

TGF-β is a critical mediator of acute lung injury

2001 • 476 citations

The Connective Tissue Growth Factor/Cysteine- Rich 61/Nephroblastoma Overexpressed (CCN) Family

1999 • 368 citations

Lung Cytokine Production in Bleomycin-Induced Pulmonary Fibrosis

1992 • 321 citations

Heparan sulfate: growth control with a restricted sequence menu

2001 • 310 citations

Treatment of metastatic cancer with tetrathiomolybdate, an anticopper, antiangiogenic agent: Phase I study.

2000 • 300 citations

Treatment of Wilson Disease With Ammonium Tetrathiomolybdate

2003 • 298 citations

SPARC is a source of copper-binding peptides that stimulate angiogenesis.

1994 • 247 citations

Connective tissue growth factor mRNA expression is upregulated in bleomycin-induced lung fibrosis

1998 • 242 citations

A role for C-C chemokines in fibrotic lung disease

1995 • 196 citations

Recognition, Diagnosis, and Management of Wilson's Disease

2000 • 188 citations

Enhanced Insulin-Like Growth Factor Binding Protein–Related Protein 2 (Connective Tissue Growth Factor) Expression in Patients with Idiopathic Pulmonary Fibrosis and Pulmonary Sarcoidosis

1999 • 182 citations

SPARC Regulates the Expression of Collagen Type I and Transforming Growth Factor-β1 in Mesangial Cells

1999 • 182 citations

Copper Control as an Antiangiogenic Anticancer Therapy: Lessons from Treating Wilson's Disease

2001 • 164 citations

Treatment of Wilson Disease With Ammonium Tetrathiomolybdate

1996 • 134 citations

Cytokines and Pulmonary Fibrosis

1996 • 133 citations

Activity and toxicity of bleomycin.

1967 • 130 citations

The Role of Copper Suppression as an Antiangiogenic Strategy in Head and Neck Squamous Cell Carcinoma

2001 • 112 citations

The Role of TGF‐β in Pulmonary Fibrosis

2007 • 92 citations

Radiotherapy and Antiangiogenic TM in Lung Cancer

2002 • 86 citations

Collagen accumulation is decreased in SPARC-null mice with bleomycin-induced pulmonary fibrosis

1999 • 78 citations

The role of IL-5 in bleomycin-induced pulmonary fibrosis

1998 • 69 citations

Neutralization of transforming growth factor-beta 1 in a mouse model of immune-induced lung fibrosis.

1994 • 47 citations

Dynamic interactions between lung fibroblasts and leukocytes: implications for fibrotic lung disease.

1998 • 33 citations

Anticytokine approaches in pulmonary fibrosis: bringing factors into focus

1997 • 30 citations

New strategies for treatment of pulmonary fibrosis.

1995 • 22 citations

Cited By (0)

No citing papers found in database

Tetrathiomolybdate therapy protects against bleomycin-induced pulmonary fibrosis in mice (2003) – Journal of Laboratory and Clinical Medicine | Metascience Observatory Explorer